Supernus Pharmaceuticals, Inc. (SUPN) Social Stream



Supernus Pharmaceuticals, Inc. (SUPN): $29.38

-0.52 (-1.74%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Supernus Pharmaceuticals Inc (SUPN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SUPN.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $40 $30 $35 $29.66 18%

The Trend in the Analyst Price Target


Over the past 28 weeks, SUPN's average price target has gone up $4.25.

Over the past 16 months, SUPN's average upside potential has been 18.85%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-20 4 40 30 35.00 26.820 30.5%
2021-09-19 4 40 30 35.00 27.280 28.3%
2021-09-18 4 40 30 35.00 27.280 28.3%
2021-09-11 4 40 30 35.00 26.590 31.63%
2021-08-17 4 40 30 35.00 24.630 42.1%
2021-08-14 4 40 30 35.00 24.740 41.47%
2021-08-07 4 40 30 35.00 26.400 32.58%
2021-08-05 4 40 30 35.00 26.590 31.63%
2021-08-01 4 40 30 35.00 26.330 32.93%
2021-07-24 4 40 30 35.00 27.270 28.35%
2021-07-17 4 40 30 35.00 26.450 32.33%
2021-07-10 4 40 30 35.00 28.410 23.2%
2021-06-16 4 40 30 35.00 33.190 5.45%
2021-06-13 4 40 30 35.00 31.200 12.18%
2021-06-05 4 40 30 35.00 29.880 17.14%
2021-04-22 4 40 28 34.50 31.300 10.22%
2021-04-17 4 40 28 34.50 31.700 8.83%
2021-03-17 4 35 25 30.75 26.460 16.21%
2021-03-13 4 35 25 30.75 26.705 15.15%
2021-03-06 4 35 25 30.75 25.145 22.29%
2021-02-27 4 35 25 30.75 26.870 14.44%
2021-02-20 4 35 26 31.00 29.610 4.69%
2021-02-13 4 35 26 31.00 30.570 1.41%
2021-02-06 4 35 26 31.00 29.420 5.37%
2021-01-30 4 35 26 29.75 29.390 1.22%
2021-01-23 4 35 26 29.75 29.940 -0.63%
2021-01-16 4 35 26 29.75 29.220 1.81%
2021-01-09 4 35 21 27.75 27.260 1.8%
2021-01-02 4 35 21 27.75 25.160 10.29%
2020-12-26 4 35 21 27.75 25.660 8.14%
2020-12-19 4 35 21 27.75 21.880 26.83%
2020-12-09 4 35 21 27.75 21.970 26.31%
2020-12-07 4 35 21 27.75 21.500 29.07%
2020-11-28 4 35 21 27.75 21.870 26.89%
2020-11-09 4 35 21 27.75 24.950 11.22%
2020-10-07 4 35 22 28.75 NA NA%
2020-09-18 4 35 22 28.75 NA NA%
2020-08-19 4 35 24 29.25 NA NA%
2020-07-24 4 33 24 29.00 NA NA%
2020-07-20 4 33 24 28.00 NA NA%
2020-06-29 4 33 24 28.00 NA NA%
2020-06-12 4 33 24 28.00 NA NA%
2020-05-28 3 33 24 27.33 NA NA%

SUPN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 1 2 1 0 0 4

The Trend in the Broker Recommendations


SUPN's average broker recommendation rating improved by 0.5 over the prior 26 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The upside potential (average analyst target price relative to current price) of SUPN is higher than 12.89% of Pharmaceutical Products stocks.
  • Supernus Pharmaceuticals Inc's number of analysts covering the stock is greater than 19.35% of stocks in the mid market cap category.
  • The average analyst price target of SUPN is higher than 68.49% of Pharmaceutical Products stocks.
  • Supernus Pharmaceuticals Inc's variance in analysts' estimates is less than 66.39% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, PLXP, FDMT and ABOS are the three stocks most similar to Supernus Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Is SUPN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8016 seconds.